E - 60-Day FRN

18918

Federal Register / Vol. 82, No. 77 / Monday, April 24, 2017 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Form name

Total
responses

Average
burden per
response
(in hours)

Total burden
hours

Delta States Rural Development Network Program Performance Improvement Measurement System ................

12

1

12

2.66

32

Total ..............................................................................

12

........................

12

........................

32

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–08187 Filed 4–21–17; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: AIDS Drug
Assistance Program Data Report, OMB
No. 0915–0345—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:

In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than June 23, 2017.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, MD 20857.
SUMMARY:

jstallworth on DSK7TPTVN1PROD with NOTICES

Number of
responses per
respondent

VerDate Sep<11>2014

13:48 Apr 21, 2017

Jkt 241001

To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call the HRSA Information Collection
Clearance Officer at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference, in compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995.
Information Collection Request Title:
AIDS Drug Assistance Program Data
Report OMB No. 0915–0345—
Extension.
Abstract: HRSA’s AIDS Drug
Assistance Program (ADAP) is funded
through the Ryan White HIV/AIDS
Program, Part B, Title XXVI of the
Public Health Service Act, which
provides funding to states and territories
through a grant. ADAP provides
medications for the treatment of HIV to
eligible clients who are low income and
uninsured or underinsured. ADAP
recipients may also use the funds to
purchase health insurance for eligible
clients and for services that enhance
access, adherence, and monitoring of
drug treatments.
The following states, territories, and
Pacific Island jurisdictions are eligible
to apply for RWHAP ADAP funding: All
50 states, the District of Columbia, the
Commonwealth of Puerto Rico, the U.S.
Virgin Islands, Guam, American Samoa,
the Commonwealth of the Northern
Mariana Islands, the Republic of Palau,
the Federated States of Micronesia, and
the Republic of the Marshall Islands. As
part of the funding requirements,
ADAPs submit reports concerning
information on clients served, eligibility
requirements, pharmaceuticals
prescribed, pricing and other sources of
support to provide HIV medication
treatment, cost data, and coordination
with Medicaid. The AIDS Drug
Assistance Program Data Report (ADR)
is submitted annually and consists of a
Recipient Report and a client-level data
file. The Recipient Report is a collection
FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00030

Fmt 4703

Sfmt 4703

of basic information about grant
recipient characteristics and policies.
The client-level data is a collection of
records (one record for each client
enrolled in the ADAP), which includes
the client’s encrypted unique identifier,
basic demographic data, enrollment
information, services received, and
clinical data.
Need and Proposed Use of the
Information: The Ryan White HIV/AIDS
Program requires the submission of
annual reports by the Secretary of HHS
to the appropriate committees of
Congress. The HIV/AIDS Bureau (HAB)
uses the ADR to evaluate the national
impact of the ADAP, by providing data
on clients being served, services being
delivered, and costs associated with
these services. The ADR is also used to
determine eligibility for the ADAP
Supplement component of the RWHAP
Part B grant (X07). The client-level data
is used to monitor health outcomes of
clients living with HIV receiving care
and treatment through the ADAP, to
monitor the use of ADAP funds in
addressing the HIV epidemic and its
impact on vulnerable communities, and
to track progress toward achieving the
national goals for HIV care and
treatment.
Likely Respondents: State/Territory
ADAPs of Ryan White HIV/AIDS
Program Part B recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.

E:\FR\FM\24APN1.SGM

24APN1

18919

Federal Register / Vol. 82, No. 77 / Monday, April 24, 2017 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Form name

Number of
responses per
respondent

Total
responses

Average
burden per
response
(in hours)

Total burden
hours

Grantee Report ....................................................................
Client-level Report ...............................................................

54
54

1
1

54
54

6
81

324
4,374

Total ..............................................................................

* 54

........................

54

........................

4,698

* The same respondents complete the Grantee Report and the Client-level Report.

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–08197 Filed 4–21–17; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Heritable
Disorders in Newborns and Children
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).

AGENCY:

ACTION:

Notice of meeting.

In accordance with the
Federal Advisory Committee Act, notice
is hereby given of the following meeting
for the Advisory Committee on
Heritable Disorders in Newborns and
Children (ACHDNC). The meeting will
be open to the public but advance
registration is required. The online
registration deadline is Thursday, May
4, 2017, 5:00 p.m. Eastern Time. Please
check the Web site for additional
guidance and registration information.
The registration link is http://
www.achdncmeetings.org/. Information
about the agenda for this meeting can be
obtained by accessing the following
Web site: http://www.hrsa.gov/
advisorycommittees/mchbadvisory/
heritabledisorders.

jstallworth on DSK7TPTVN1PROD with NOTICES

SUMMARY:

The meeting will be held on May
11, 2017, 9:00 a.m. to 5:00 p.m. and May
12, 2017, 9:00 a.m. to 3:00 p.m.

DATES:

VerDate Sep<11>2014

13:48 Apr 21, 2017

Jkt 241001

This meeting will be held
in-person and by webcast. The address
for the meeting is 5600 Fishers Lane, 5th
Floor Pavilion, Rockville, MD 20857.
Webcast information will be emailed to
you after you register.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the ACHDNC should contact
Ann Ferrero, Maternal and Child Health
Bureau (MCHB), HRSA, in one of three
ways: (1) Send a request to Ann Ferrero,
MCHB, HRSA 5600 Fishers Lane, Room
18N100C, Rockville, Maryland 20857;
(2) call 301–443–3999 or (3) send an
email to: AFerrero@hrsa.gov. More
information on the Advisory Committee
is available at the Advisory Committee’s
Web site, provided above.
SUPPLEMENTARY INFORMATION: The
ACHDNC, as authorized by Public
Health Service Act, Title XI, § 1111 (42
U.S.C. 300b–10), provides advice to the
Secretary of HHS on the development of
newborn screening activities,
technologies, policies, guidelines, and
programs for effectively reducing
morbidity and mortality in newborns
and children having, or at risk for,
heritable disorders. In addition,
ACHDNC’s recommendations regarding
inclusion of additional conditions and
inherited disorders for screening which
have been adopted by the Secretary are
then included in the Recommended
Uniform Screening Panel (RUSP).
Conditions listed on the RUSP
constitute part of the comprehensive
guidelines supported by HRSA for
infants, children, and adolescents.
Pursuant to section 2713 of the Public
Health Service Act, codified at 42 U.S.C.
300gg–13, non-grandfathered health
plans and health insurance issuers are
required to cover screenings included in
the HRSA-supported comprehensive
guidelines without charging a copayment, co-insurance, or deductible for
plan years (i.e., policy years) beginning
on or after the date that is one year from
the Secretary’s adoption of the
condition for screening. the meeting
will include: (1) Presentations and
discussion on the process of identifying
and following up on out of range
ADDRESSES:

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

newborn screening results; (2) a
presentation on newborn screening
quality assurance programs; (3)
presentations on the clinical and public
health impact of Critical Congenital
Heart Defects screening; (4) discussion
and possible vote on a report on
Medical Foods for Inborn Errors of
Metabolism; (5) a presentation,
discussion, and possible vote on
whether to move a nomination forward
to evidence review for spinal muscular
atrophy (SMA); and (6) updates from the
Laboratory Standards and Procedures
workgroup, Follow-up and Treatment
workgroup, and Education and Training
workgroup.
The Committee will not be voting on
a proposed addition of a condition to
the RUSP. The final meeting agenda will
be available two (2) days prior to the
meeting on the Committee’s Web site:
http://www.hrsa.gov/
advisorycommittees/mchbadvisory/
heritabledisorders.
Members of the public may submit
written and/or present oral comments at
the meeting. All comments are part of
the official Committee record. Advance
registration is required to submit written
comments and/or present oral
comments. Written comments must be
submitted by April 28, 2017, 12:00 p.m.
Eastern Time to be included in the May
meeting briefing book. Written
comments should identify the
individual’s name, address, email,
telephone number, professional or
organization affiliation, background or
area of expertise (i.e., parent, family
member, researcher, clinician, public
health, etc.) and the topic/subject
matter.
Individuals who wish to provide oral
comments must register by Thursday,
May 4, 2017, 5:00 p.m. Eastern Time. To
ensure that all individuals who have
registered to make oral comments can be
accommodated, the allocated time may
be limited. Individuals who are
associated with groups or have similar
interests may be requested to combine
their comments and present them
through a single representative. No
audiovisual presentations are permitted.

E:\FR\FM\24APN1.SGM

24APN1